Dr francesca kinsella University Hospitals Birmingham CCH_Bham Mel Calvert Alastair Denniston Chakraverty Lab James Davies UoB MDS R&KT Office University of Oxford Charlie Craddock CBE NHSBT R&D Looking forward to connecting with the team University Hospitals Birmingham Charlie Craddock CBE Mel Calvert Dr francesca kinsella in the near future re PPIE and #carttherapy #aftercare #app

Finding the right treatment when living with a health condition like chronic myeloid leukemia (CML) can be challenging. Learn how Al navigated his CML treatment journey and found the right fit for him.

#NovartisCollaborator

#chronicmyeloidleukemia #Cancer #Leukemia

CAR-T constructs targeting CD19, such as axicabtagene ciloleucel and brexucabtagene autoleucel, have the highest risk of ICANs. Tisagenlecleucel and idecabtagene vicleucel have intermediate risk, while lisocabtagene ciloleucel has the lowest. #CARTtherapy #ICANs

Excited to be invited to talk about “infections in CAR-T,” among this excellent lineup of speakers. fredhutch.org/en/events/4th-…
Dr Roy Chemaly Joshua Hill, MD Steven “😷 & Vaccinated” Pergam, MD, MPH Michael Ison, MD MS genovefa papanicolaou Jim Boonyaratanakornkit Alpana Waghmare Saima Aslam & Per Ljungman. Miss Francisco Marty, MD Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx

Meet the bra designed just for small boobs that fits like a second skin ☁️ No more cup gaps, awkward padding or digging wires. Just you in all your glory 🔥

CAR-T Cell therapies & gene editing are going to change our expectations on health & longevity. Understanding these technologies are recommended as many will be users in the not too distant future #Cancer #LONGEVITY Andrew D. Huberman, Ph.D. Peter Attia Arovella Therapeutics ASX: ALA Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx

Impact of serum‑free media on the expansion and functionality of CD19.CAR T‑cells
spandidos-publications.com/10.3892/ijmm.2…

Nico Gagelmann LymphomaAction Lymphoma Hub The Leukemia & Lymphoma Society @lymphoma Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Rahul Banerjee, MD, FACP Heartfelt congratulations Nico, so happy for you😊💫

Try 1 roll of custom packaging tape for $9.

Rahul Banerjee, MD, FACP Dr Roy Chemaly Joshua Hill, MD Steven “😷 & Vaccinated” Pergam, MD, MPH Michael Ison, MD MS genovefa papanicolaou Jim Boonyaratanakornkit Alpana Waghmare Saima Aslam Francisco Marty, MD Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Fred Hutchinson Cancer Center Thanks Rahul. Can’t wait to finally meet in person

Save the date 🗓️ April 30 - May 3rd, 2023

The 4th Symposium on Infectious Diseases in the Immunocompromised Host is again in Seattle, WA in 2023. #IDSymp23

Great opportunity to meet & learn from leaders in #TxID /Immunosuppressed ID

Please RT!

fredhutch.org/en/events/4th-…

Nico Gagelmann LymphomaAction Lymphoma Hub The Leukemia & Lymphoma Society @lymphoma Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Rahul Banerjee, MD, FACP 👏🏻👏🏻👏🏻
Were all active infections bacterial? It looks that for those with severe neutropenia the boost didn’t help so much. So, the earlier you got the boost, the better. 😀

Nico Gagelmann LymphomaAction Lymphoma Hub The Leukemia & Lymphoma Society @lymphoma Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Rahul Banerjee, MD, FACP Congratulations @nicogagelmann!

Nico Gagelmann LymphomaAction Lymphoma Hub The Leukemia & Lymphoma Society @lymphoma Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Rahul Banerjee, MD, FACP Congratulations! Really important work and a huge benefit for patients!

Lisocabtagene maraleucel in chronic lymphocytic leukaemia and small lymphocytic lymphoma (TRANSCEND CLL 004): a multicentre, open-label, single-arm, phase 1–2 study - The Lancet thelancet.com/journals/lance…

Nico Gagelmann LymphomaAction Lymphoma Hub The Leukemia & Lymphoma Society @lymphoma Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Rahul Banerjee, MD, FACP Congratulations 👏

Early GCSF administration increases the risk of cytokine release syndrome in B-ALL patients receiving anti-CD19 #CAR T therapy
onlinelibrary.wiley.com/doi/epdf/10.10…
#CAR T #bmtsm #immunotherapy #tcellrx #ICAN #CRS #CAR Tcells #CellTherapy #Gene #Gene therapy
ASTCT
Chimeric Antigen Receptor T-Cell (CAR-T)

Dreams come be true. #EBMT23 #EBMT2023 #hematologynurse #CARTcells #CARTTherapy #research #nurseresearch #hematorules #hematoCAUSA

FDA Accepts Biologics License Applications for exa-cel) for Severe SCD and Transfusion-Dependent Beta Tha| CRISPR Therapeutics
#CART #bmtsm #CART cell #immunotherapy #tcellrx #ICAN #CRS #CART cells #CellTherapy #Gene #Gene therapy
ASTCT
⁦Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx⁩ ir.crisprtx.com/news-releases/…

Fresh IBCC chapter: CAR-T cell therapy recipient in the ICU
🚔sorting out CRS (cytokine release syndrome), ICANS (immune effector-cell neurotoxicity syndrome), & HLH.
🚔while simultaneously excluding/treating alternative diagnoses, especially infection.
emcrit.org/ibcc/cart/

Prof Emma Morris 💙 Thanks Prof Emma Morris 💙 T2EVOLVE Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx

Efficacy and toxicity of CD19 CAR-T cell therapy for lymphoma in solid organ transplant recipients: a systematic review and meta-analysis - Transplantation and Cellular Therapy, ⁦ASTCT⁩ ⁦ASTCT_Journal⁩ astctjournal.org/article/S2666-…

Bilal Abid Dr Roy Chemaly Joshua Hill, MD Steven “😷 & Vaccinated” Pergam, MD, MPH Michael Ison, MD MS genovefa papanicolaou Jim Boonyaratanakornkit Alpana Waghmare Saima Aslam Francisco Marty, MD Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Excited to hear your talk and meet you!

Yoram Kaduri is a Fighter – #CARTTherapy at #Hadassah Gave Him a Reason to Fight hadassahinternational.org/yoram-kaduri-i…
#myeloma #oncology #cancer

Nico Gagelmann LymphomaAction Lymphoma Hub The Leukemia & Lymphoma Society @lymphoma Chimeric Antigen Receptor T-Cell (CAR-T) & Gene Rx Rahul Banerjee, MD, FACP Any concerns about graft contamination with malignant cells?